Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Recent developments in esophageal adenocarcinoma

(2013) Jesper Lagergren et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

(2013) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

“Systematic Reviews and Meta-analyses” in Clinical Gastroenterology and Hepatology

(2012) Fasiha Kanwal et al.   Clinical Gastroenterology and Hepatology

Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus

(2012) Florine Kastelein et al.   Clinical Gastroenterology and Hepatology

A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E2 in Patients With Barrett's Esophagus

(2012) Gary W. Falk et al.   GASTROENTEROLOGY

The Role of Bile Acids in the Neoplastic Progression of Barrett's Esophagus - A Short Representative Overview

(2012) S. Jürgens et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based Study

(2011) Kee Wook Jung et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study

(2011) M Sikkema et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus

(2011) Stuart J. Spechler et al.   GASTROENTEROLOGY

Risk Factors for Progression of Low-Grade Dysplasia in Patients With Barrett's Esophagus

(2011) Sachin Wani et al.   GASTROENTEROLOGY

Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis

(2011) Linda M. Liao et al.   GASTROENTEROLOGY

GRADE guidelines: 7. Rating the quality of evidence—inconsistency

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus

(2010) Dang M. Nguyen et al.   GASTROENTEROLOGY

Barrett's oesophagus, proton pump inhibitors and gastrin: the fog is clearing

(2010) E. J. Kuipers   GUT

Use of Proton Pump Inhibitors and Risk of Progression of Barrett's Esophagus to Neoplastic Lesions

(2009) Farhad Islami et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-term Safety Concerns with Proton Pump Inhibitors

(2009) Tauseef Ali et al.   AMERICAN JOURNAL OF MEDICINE

Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus

(2009) Dang M. Nguyen et al.   Clinical Gastroenterology and Hepatology

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

(2009) Marjolein Sikkema et al.   Clinical Gastroenterology and Hepatology

Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications

(2009) Ramalinga R. Kedika et al.   DIGESTIVE DISEASES AND SCIENCES

Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo

(2009) J. A. Obszynska et al.   GUT

Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett's Esophagus

(2008) Chin Hur et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Chemoprevention and Barrett's Esophagus: Decisions, Decisions

(2008) Gary W. Falk et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus

(2008) Piers A. C. Gatenby et al.   DISEASES OF THE ESOPHAGUS